Mary K Hargadon-zester, MS, LCMFT | |
15312 Spencerville Ct, Suite 301, Burtonsville, MD 20866-1666 | |
(301) 421-9100 | |
Not Available |
Full Name | Mary K Hargadon-zester |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 15312 Spencerville Ct, Burtonsville, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1962619346 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 040 (Maryland) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mary K Hargadon-zester, MS, LCMFT 15312 Spencerville Ct, Suite 301, Burtonsville, MD 20866-1666 Ph: (301) 421-9100 | Mary K Hargadon-zester, MS, LCMFT 15312 Spencerville Ct, Suite 301, Burtonsville, MD 20866-1666 Ph: (301) 421-9100 |
News Archive
The work, published by the Esteve Foundation, reveals that gender differences in the manifestation of the diseases result in poorer diagnosis and treatment for women.
Researchers at Mount Sinai School of Medicine have found that exposure during pregnancy to a family of pesticides called organophosphates may impair child cognitive development. The findings are published online in Environmental Health Perspectives.
BIOLASE Technology, Inc. today announced that it is an inaugural winner of the Tech Evolution Award, an award that recognizes an elite group of companies that offer exceptional technologies that are transforming the technology industry. BIOLASE was announced as a recipient at a reception held on October 6 at The Island Hotel in Newport Beach, CA, by Deloitte & Touche LLP, host of the Tech Evolution Award and the Technology Fast 500.
Scientists hope to have paved the way for the development of potentially new life-saving treatments to be administered to seriously injured patients in the critical first hour of injury.
Aromatase inhibitors, the same drugs that have buoyed long-term survival rates among breast cancer patients, also carry side effects including joint pain so severe that many patients discontinue these lifesaving medicines. New University of Pennsylvania School of Medicine research, however, has uncovered patterns that may help clinicians identify and help women at risk of these symptoms sooner in order to increase their chances of sticking with their treatment regimen.
› Verified 1 days ago
Joan E. Delovitch, M.S., L.C.M.F.T. Couples Therapy Medicare: Not Enrolled in Medicare Practice Location: 15312 Spencerville Ct, Suite 301, Burtonsville, MD 20866 Phone: 301-421-9100 |